Accuray's QQ4 2025 results show a modest sequential revenue improvement but a year-on-year revenue decline of 5.02% to USD 127.54 million. The quarter delivered a positive operating profit of USD 4.23 million and EBITDA of USD 10.47 million, with net income of USD 1.12 million and basic/diluted EPS of USD 0.0105 / USD 0.0100, respectively. The company ended the quarter with a cash balance of USD 57.99 million and a net debt position of USD 118.39 million, underpinned by a solid current asset base (USD 317.47 million) and total assets of USD 470.24 million. The balance sheet reflects a mature negative retained earnings position (USD -519.27 million) and significant deferred revenue (USD 121.07 million total), suggesting a mix of services, maintenance contracts, and recurring revenue streams that can support ongoing cash flow. While gross margin stood at 30.56%, below typical peers in the medtech space, operating leverage and cost controls produced material EBITDA uplift QoQ. Management commentary (when available) will be critical to confirm sustainability of product mix dynamics and longer-term profitability given leverage and R&D investment levels.
Key Performance Indicators
Revenue
Decreasing
127.54M
QoQ: 12.63% | YoY: -5.02%
Gross Profit
Increasing
38.98M
30.56% margin
QoQ: 23.25% | YoY: 1.37%
Operating Income
Decreasing
4.23M
QoQ: 304.39% | YoY: -37.89%
Net Income
Decreasing
1.12M
QoQ: 186.58% | YoY: -66.84%
EPS
Decreasing
0.01
QoQ: 183.33% | YoY: -69.12%
Revenue Trend
Margin Analysis
Financial Highlights
Revenue: USD 127.543 million; YoY -5.02%; QoQ +12.63%
Gross Profit: USD 38.979 million; Gross Margin 30.56%; YoY +1.37%; QoQ +23.25%
Operating Income: USD 4.234 million; Operating Margin 3.32%; YoY -37.89%; QoQ +304.39%
Net Income: USD 1.123 million; Net Margin 0.88%; YoY -66.84%; QoQ +186.58%
EPS: USD 0.0105 (basic); USD 0.0100 (diluted); YoY -69.12%; QoQ +183.33%
EBITDA: USD 10.473 million; EBITDA Margin 8.21%
Cash & Equivalents: USD 57.99 million; Total Debt: USD 176.38 million; Net Debt: USD 118.39 million
Total Current Assets/Liabilities: USD 317.47 million vs. USD 195.43 million (current); Current Ratio ~1.63; Quick Ratio below 1 (~0.72) due to high working capital components
Shareholders’ Equity: USD 81.17 million; Retained Earnings: USD -519.27 million; Goodwill: USD 57.80 million; Deferred Revenue (current/non-current): USD 94.50 million / USD 26.57 million; Total Deferred Revenue: USD 121.07 million
Income Statement
Metric
Value
YoY Change
QoQ Change
Revenue
127.54M
-5.02%
12.63%
Gross Profit
38.98M
1.37%
23.25%
Operating Income
4.23M
-37.89%
304.39%
Net Income
1.12M
-66.84%
186.58%
EPS
0.01
-69.12%
183.33%
Key Financial Ratios
Management Insights Available for Members
Get exclusive access to management commentary, earnings call quotes, and forward guidance from company leadership.